维普中文期刊产品整合服务
9篇 您的检索式:作者名="Meani E"
    题名 作者 年代 出处 被引量
1The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI-420) after intravenousadministrativeation of erlotinib in non-human primates显示文摘Meany HJ Fox E Mccully C 2008Cancer Chemother Pharmacol2008,62,3:1
2A comparative study of the use of bioactive glass S53P4and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis:a retrospectivecomparative study显示文摘RomanòCL Logoluso N Meani E 2014Bone Joint J2014,96,6:1
3The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI- 420) after intravenous administration of erlotinib in nonhuman pri- mate 显示文摘Meany HJ Fox E McCully C 2008Cancer Chemother Pharmacol2008,62,3:1
4The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite(OSI-420)after intravenous administrativeation of erlotinib in non-human primates 显示文摘Meany HJ Fox E Mccully C 2008Cancer Chemotherapy Pharmaco2008,62,3:1
5A comparative study of the use of bioactive glass $53P4 and antibiotic-loaded calcium- based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study 显示文摘Romant~ CL Logoluso N Meani E et at 2014Bone Joint J2014,96,6:1
6Sox2 regulatory sequences direct expression of a( beta)-geotransgene to telencephalic neural stem cells and precursors ofthe mouse embryo, revealing regionalization of gene expressionin CNS stem cells显示文摘Zappone MV Galli R Catena R Meani N De Biasi S Mattei E etal 2000Development2000,127,11:1
7Pharmacokinetics oftemozolomide administered in combination with 06 -benzylguaninein children and adolescents with refractory solid tumors 显示文摘MEANY HJ WARREN KE FOX E 2009Cancer Chemother Pharm2009,65,1:1
8A com- parative study of the use of bioactive glass $53P4 and antibiotic- loaded calcium- based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study 显示文摘ROMANbC L LOGOLUSO N MEANI E 2014Bone Joint J2014,96,6:1
918-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibrcmas (PN) or malignant peripheral nerve sheath tumors (MPNST)显示文摘Meany H Dombi E Reynolds J 2013Pediatr Blood Cancer2013,60,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费